AGL 37.91 Decreased By ▼ -0.11 (-0.29%)
AIRLINK 215.50 Increased By ▲ 18.14 (9.19%)
BOP 9.80 Increased By ▲ 0.26 (2.73%)
CNERGY 6.83 Increased By ▲ 0.92 (15.57%)
DCL 9.18 Increased By ▲ 0.36 (4.08%)
DFML 39.00 Increased By ▲ 3.26 (9.12%)
DGKC 100.80 Increased By ▲ 3.94 (4.07%)
FCCL 36.50 Increased By ▲ 1.25 (3.55%)
FFBL 88.94 Increased By ▲ 6.64 (8.07%)
FFL 14.49 Increased By ▲ 1.32 (10.02%)
HUBC 134.52 Increased By ▲ 6.97 (5.46%)
HUMNL 13.65 Increased By ▲ 0.15 (1.11%)
KEL 5.69 Increased By ▲ 0.37 (6.95%)
KOSM 7.39 Increased By ▲ 0.39 (5.57%)
MLCF 46.00 Increased By ▲ 1.30 (2.91%)
NBP 61.20 Decreased By ▼ -0.22 (-0.36%)
OGDC 233.25 Increased By ▲ 18.58 (8.66%)
PAEL 40.75 Increased By ▲ 1.96 (5.05%)
PIBTL 8.57 Increased By ▲ 0.32 (3.88%)
PPL 203.15 Increased By ▲ 10.07 (5.22%)
PRL 41.15 Increased By ▲ 2.49 (6.44%)
PTC 28.38 Increased By ▲ 2.58 (10%)
SEARL 108.40 Increased By ▲ 4.80 (4.63%)
TELE 8.75 Increased By ▲ 0.45 (5.42%)
TOMCL 36.00 Increased By ▲ 1.00 (2.86%)
TPLP 13.80 Increased By ▲ 0.50 (3.76%)
TREET 24.38 Increased By ▲ 2.22 (10.02%)
TRG 61.15 Increased By ▲ 5.56 (10%)
UNITY 34.47 Increased By ▲ 1.50 (4.55%)
WTL 1.74 Increased By ▲ 0.14 (8.75%)
BR100 12,244 Increased By 517.6 (4.41%)
BR30 38,419 Increased By 2042.6 (5.62%)
KSE100 113,924 Increased By 4411.3 (4.03%)
KSE30 36,044 Increased By 1530.5 (4.43%)
World

'No evidence' people with coronavirus are immunised: WHO

The warning suggests that the issuance of "immune passports" may promote the continued spread of the pandemic.
Published April 25, 2020
  • The warning suggests that the issuance of "immune passports" may promote the continued spread of the pandemic.

GENEVA: The World Health Organization (WHO) warned on Saturday that there is no evidence that people who test positive for the new coronavirus are immunised and protected against reinfection.

The warning suggests that the issuance of "immune passports" may promote the continued spread of the pandemic.

"There is currently no evidence that people who have recovered from #COVID19 and have antibodies are protected from a second infection," WHO said in a statement.

"As of 24 April 2020, no study has evaluated whether the presence of antibodies to SARS-CoV-2 confers immunity to subsequent infection by this virus in humans."

Some governments, wanting a gradual return to work and the resumption of economic activity, have put forward the idea of issuing documents attesting to the immunity of people on the basis of serological tests revealing the presence of antibodies in the blood.

But the effectiveness of an immunisation thanks to antibodies has still not been established and the available scientific data do not justify the granting of an "immune passport" or a "certificate of absence of risk", warns the WHO.

At this point in the pandemic, there is not enough evidence about the effectiveness of antibody-mediated immunity to guarantee the accuracy of an "immunity passport" or "risk-free certificate."

"People who assume that they are immune to a second infection because they have received a positive test result may ignore public health advice," the WHO said.

"The use of such certificates may therefore increase the risks of continued transmission."

WHO also believes that the serological tests currently used "need additional validation to determine their accuracy and reliability".

In particular, the tests need to make it possible to distinguish the immune response to the novel coronavirus from the antibodies produced during an infection by another of the six known human coronaviruses, four of which are widespread, causing mild colds.

The other two are responsible for MERS (Middle East Respiratory Syndrome) and SARS (Severe Acute Respiratory Syndrome).

"People infected with one or the other of these viruses are capable of producing antibodies which interact with antibodies produced in response to infection caused by SARS-CoV-2", said WHO, empasising the importance of being able to identify them.

 

Comments

Comments are closed.